ACE2 and COVID-19: Non-boosted convalescents appear to be less protected from COVID-19 reinfection than dually vaccinated COVID-19 naïves according to large cohort analyses [31], which again compares very well with our results, as the respective subcohort in this study also showed low antibody titers and little ACE2 binding inhibition.